OBIO

Orchestra Biomed Holdings
$3.82
+$0.08 (+2.14%)Jul 27, 2026
2.2FairMoatMint rating

MoatMint rates Orchestra Biomed Holdings (OBIO) 2.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.3 out of 10.

Key metrics

The numbers that frame OBIO today
Market cap
$228.74M
P/E (TTM)
-4.2
EV / FCF
-4.2
Gross margin
99.5%
EV / Sales
7.2
ROIC
-73.5%
Div yield
0%
Debt / equity
0.8
52wk Low
$2.20
52wk High
$5.42

OBIO stock rating

How OBIO scores on quality, value, growth, momentum and financial health
2.2out of 10
Fair overallFair business, expensive priceTop 78% of ~5,000 US stocks
QualityFair2.3/10
GrowthFair3.9/10
MomentumNeutral5.8/10
ValuePoor1.5/10
Financial HealthFair3.1/10

Growth

Revenue and earnings trend for OBIO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about OBIO
Is Orchestra Biomed Holdings a good buy?
Hold. Orchestra Biomed Holdings has poor quality and mixed momentum. The setup is weak overall. Growth looks weak. That could put pressure on the long-term business case. We think Orchestra Biomed Holdings is selling at a very high price.
What is the market capitalization of OBIO?
Orchestra Biomed Holdings's market capitalization is $228.74M.
What is the P/E ratio for OBIO stock?
Orchestra Biomed Holdings's current P/E ratio is -4.2.
What is the 52-week high for OBIO stock?
The 52-week high for Orchestra Biomed Holdings is $5.42. The current close of $3.82 is 29.6% below that high.
What is the 52-week low for OBIO stock?
The 52-week low for Orchestra Biomed Holdings is $2.20. The current close of $3.82 is 73.6% above that low.
Does OBIO stock pay dividends?
Orchestra Biomed Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for OBIO?
Orchestra Biomed Holdings's Debt / Equity ratio is 0.82.